Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Siegel

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Alimentary Pharmacology & Therapeutics|November 19, 2010
Review article: explaining risks of inflammatory bowel disease therapy to patientsC A Siegel
Alimentary Pharmacology & Therapeutics|June 21, 2005
Review article: practical management of inflammatory bowel disease patients taking immunomodulatorsC A Siegel, B E Sands
Alimentary Pharmacology & Therapeutics|March 20, 2014
Review article: integrating budesonide-MMX into treatment algorithms for mild-to-moderate ulcerative colitisS Danese, C A Siegel, L Peyrin-Biroulet
Gut|August 5, 2009
Modelling dysplasia detection in ulcerative colitis: clinical implications of surveillance intensityD Awais, C A Siegel, P D R Higgins
Alimentary Pharmacology & Therapeutics|April 18, 2014
Systematic review: The safety and efficacy of hyperbaric oxygen therapy for inflammatory bowel diseaseP S Dulai, M W Gleeson, D Taylor, et al.
Journal of Crohn'S & Colitis|March 6, 2018
Changes in Disease Behaviour and Location in Patients With Crohn's Disease After Seven Years of Follow-Up: A Danish Population-based Inception CohortB Lo, M K Vester-Andersen, I Vind, et al.
Inflammatory Bowel Diseases|February 17, 2012
Setting priorities for comparative effectiveness research in inflammatory bowel disease: results of an international provider survey, expert RAND panel, and patient focus groupsA S Cheifetz, G Y Melmed, B Spiegel, et al.
Alimentary Pharmacology & Therapeutics|November 17, 2015
A validated web-based tool to display individualised Crohn's disease predicted outcomes based on clinical, serologic and genetic variablesC A Siegel, H Horton, L S Siegel, et al.
Alimentary Pharmacology & Therapeutics|June 3, 2015
Clinical and demographic characteristics predictive of treatment outcomes for certolizumab pegol in moderate to severe Crohn's disease: analyses from the 7-year PRECiSE 3 studyW J Sandborn, G Y Melmed, D P B McGovern, et al.
The American Journal of Gastroenterology|August 26, 2015
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-TargetL Peyrin-Biroulet, W Sandborn, B E Sands, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Alimentary Pharmacology & Therapeutics|November 19, 2010
Review article: explaining risks of inflammatory bowel disease therapy to patientsC A Siegel
Alimentary Pharmacology & Therapeutics|June 21, 2005
Review article: practical management of inflammatory bowel disease patients taking immunomodulatorsC A Siegel, B E Sands
Alimentary Pharmacology & Therapeutics|March 20, 2014
Review article: integrating budesonide-MMX into treatment algorithms for mild-to-moderate ulcerative colitisS Danese, C A Siegel, L Peyrin-Biroulet
Gut|August 5, 2009
Modelling dysplasia detection in ulcerative colitis: clinical implications of surveillance intensityD Awais, C A Siegel, P D R Higgins
Alimentary Pharmacology & Therapeutics|April 18, 2014
Systematic review: The safety and efficacy of hyperbaric oxygen therapy for inflammatory bowel diseaseP S Dulai, M W Gleeson, D Taylor, et al.
Journal of Crohn'S & Colitis|March 6, 2018
Changes in Disease Behaviour and Location in Patients With Crohn's Disease After Seven Years of Follow-Up: A Danish Population-based Inception CohortB Lo, M K Vester-Andersen, I Vind, et al.
Inflammatory Bowel Diseases|February 17, 2012
Setting priorities for comparative effectiveness research in inflammatory bowel disease: results of an international provider survey, expert RAND panel, and patient focus groupsA S Cheifetz, G Y Melmed, B Spiegel, et al.
Alimentary Pharmacology & Therapeutics|November 17, 2015
A validated web-based tool to display individualised Crohn's disease predicted outcomes based on clinical, serologic and genetic variablesC A Siegel, H Horton, L S Siegel, et al.
Alimentary Pharmacology & Therapeutics|June 3, 2015
Clinical and demographic characteristics predictive of treatment outcomes for certolizumab pegol in moderate to severe Crohn's disease: analyses from the 7-year PRECiSE 3 studyW J Sandborn, G Y Melmed, D P B McGovern, et al.
The American Journal of Gastroenterology|August 26, 2015
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-TargetL Peyrin-Biroulet, W Sandborn, B E Sands, et al.
Pageof 1